Abbott Laboratories (ABT)
$102.61+0.78%Close
SELLRECOVERY · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV14.6%–53.0%
- Market cap
- $178.7B
- Beta
- 0.58
- Div yield
- 3.03%
- P/E (TTM)
- 33.01
- IV-%ile
- 94
- IV ATM
- 37.8%
- Short % float
- 0.79%
- Days to cover
- 1.5
- SI change
- -31.5%
- 1W
- +4.53%
- 1M
- -0.47%
- vs SPY 1W
- +4.67%
- vs SPY 1M
- -2.97%
Industry peers
FMP comparable companies · ranked by market cap
- JNJSELLJohnson & Johnson$618.1BBEARQ 22$256.48-5.73%
- TMOBUYThermo Fisher Scientific Inc.$241.1BBULLQ 18$651.98+0.12%
- DHRBUYDanaher Corporation$152.9BRECOVERYQ 36$217.46+0.74%
- MDTSELLMedtronic Plc$112.3BRECOVERYQ 14$87.75+1.17%
- SYKBUYStryker Corporation$106.2BRECOVERYQ 25$276.97-0.02%
- BSXSELLBoston Scientific Corporation$62.5BRECOVERYQ 6$42.04-1.21%
- BDXBUYBecton, Dickinson and Company$50.4BBULLQ 21$182.75-0.80%
- EWSELLEdwards Lifesciences Corporation$48.5BBEARQ 18$84.24-1.30%
- GEHCBUYGE HealthCare Technologies Inc.$29.0BRECOVERYQ 7$64.22+1.55%
- SMMNYSiemens Healthineers AG$24.2B$21.64
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ABT?
- LOPJLB’s latest quantitative signal on Abbott Laboratories (ABT) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ABT in?
- Abbott Laboratories (ABT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Abbott Laboratories (ABT) do?
- Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmac…